For step-by-step instructions and vial size comparisons, see the full Retatrutide Reconstitution Guide
Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5
For larger vials you can use up to 5 mL more bac water makes microdosing easier, but insulin needles usually max out at 1 mL per injection
Tretinoin reliably produces what dermatologists call retinoid dermatitis or the 'retinization' period during the first two to eight weeks: redness, flaking, dryness, stinging, and sometimes a temporary flare of breakouts
Better glycemic control reduces glucotoxicity, which contributes to liver inflammation and fibrosis